Rubicon develops and commercializes molecular tools for the biological research and diagnostics markets. It has proprietary reagents and protocols for amplification of DNA and RNA that improve the performance of analytical platforms for research and diagnostic applications. Its kits are used by major universities and institutes, as well as biotechnology, diagnostic and pharmaceutical companies. Rubicon also partners with diagnostic companies to discover and commercialize cancer biomarkers.
Keywords: DNA RNA molecular diagnostics pre-implantation pre-natal cancer